ZHONGCHAO INC-CLASS A (ZCMD)

KYG9897X1152 - Common Stock

1.81  -0.13 (-6.81%)

After market: 1.75 -0.06 (-3.31%)

Fundamental Rating

3

Overall ZCMD gets a fundamental rating of 3 out of 10. We evaluated ZCMD against 67 industry peers in the Diversified Consumer Services industry. While ZCMD has a great health rating, there are worries on its profitability. ZCMD has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year ZCMD has reported negative net income.
ZCMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZCMD reported negative net income in multiple years.
In multiple years ZCMD reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -27.15%, ZCMD is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
ZCMD's Return On Equity of -36.93% is on the low side compared to the rest of the industry. ZCMD is outperformed by 64.62% of its industry peers.
Industry RankSector Rank
ROA -27.15%
ROE -36.93%
ROIC N/A
ROA(3y)-17.79%
ROA(5y)-3.55%
ROE(3y)-24.02%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZCMD has a Gross Margin (51.28%) which is in line with its industry peers.
ZCMD's Gross Margin has declined in the last couple of years.
ZCMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.77%
GM growth 5Y-7.7%

8

2. Health

2.1 Basic Checks

ZCMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZCMD has been reduced compared to 1 year ago.
The number of shares outstanding for ZCMD has been reduced compared to 5 years ago.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 1.99 indicates that ZCMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.99, ZCMD perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
ZCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.99
ROIC/WACCN/A
WACC7.54%

2.3 Liquidity

A Current Ratio of 6.05 indicates that ZCMD has no problem at all paying its short term obligations.
ZCMD's Current ratio of 6.05 is amongst the best of the industry. ZCMD outperforms 95.38% of its industry peers.
ZCMD has a Quick Ratio of 5.94. This indicates that ZCMD is financially healthy and has no problem in meeting its short term obligations.
ZCMD's Quick ratio of 5.94 is amongst the best of the industry. ZCMD outperforms 95.38% of its industry peers.
Industry RankSector Rank
Current Ratio 6.05
Quick Ratio 5.94

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.91% over the past year.
The Revenue has been growing slightly by 1.01% in the past year.
Measured over the past years, ZCMD shows a quite strong growth in Revenue. The Revenue has been growing by 8.60% on average per year.
EPS 1Y (TTM)15.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.89%
Revenue 1Y (TTM)1.01%
Revenue growth 3Y2.61%
Revenue growth 5Y8.6%
Sales Q2Q%-19.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

ZCMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZCMD!.
Industry RankSector Rank
Dividend Yield N/A

ZHONGCHAO INC-CLASS A

NASDAQ:ZCMD (12/20/2024, 8:00:02 PM)

After market: 1.75 -0.06 (-3.31%)

1.81

-0.13 (-6.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-04 2022-10-04/dmh
Earnings (Next)12-13 2022-12-13/dmh
Inst Owners0.73%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap10.15M
Analysts0
Price TargetN/A
Short Float %0.34%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF 3.74
P/B 0.57
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.48
OCFY26.76%
SpS3.1
BVpS3.15
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.15%
ROE -36.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.28%
FCFM N/A
ROA(3y)-17.79%
ROA(5y)-3.55%
ROE(3y)-24.02%
ROE(5y)-6.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.77%
GM growth 5Y-7.7%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 868.13%
Cap/Sales 16.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.05
Quick Ratio 5.94
Altman-Z 1.99
F-Score5
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)370.14%
Cap/Depr(5y)493.14%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.01%
Revenue growth 3Y2.61%
Revenue growth 5Y8.6%
Sales Q2Q%-19.54%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-142.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y502.04%
OCF growth 3YN/A
OCF growth 5Y-47.14%